カテゴリ： 世界, 部品/材料, Market Monitor Global

ドキソルビシン塩酸塩APIのグローバル市場展望 2023年-2029年：純度≧98%、純度<98%

■ 英語タイトル：Doxorubicin Hydrochloride API Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC01782）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC01782
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：化学＆材料
■ ページ数：73
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ドキソルビシン塩酸塩APIのグローバル市場展望 2023年-2029年：純度≧98%、純度<98%]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のドキソルビシン塩酸塩API市場規模と予測を収録しています。・世界のドキソルビシン塩酸塩API市場：売上、2018年-2023年、2024年-2029年
・世界のドキソルビシン塩酸塩API市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のドキソルビシン塩酸塩API市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「純度≧98%」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ドキソルビシン塩酸塩APIのグローバル主要企業は、Intas Pharmaceuticals Ltd、 Olon Spa、 Sterling Biotech Ltd、 Synbias Pharma Ag、 Teva Pharmaceutical Industries Ltd、 Meiji Seika Pharma Co Ltd、 Microbiopharm Japan Co Ltd、 Pharmacia And Upjohn Co、 Boryung Pharmaceutical、 Transo-Pharm Handels Gmbh、 Dzd Heze Pharmaceutical Co Ltd、 Zhejiang Hisun Pharmaceutical、 Guangdong Lingnan Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ドキソルビシン塩酸塩APIのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のドキソルビシン塩酸塩API市場：タイプ別、2018年-2023年、2024年-2029年
世界のドキソルビシン塩酸塩API市場：タイプ別市場シェア、2022年
・純度≧98%、純度<98%

世界のドキソルビシン塩酸塩API市場：用途別、2018年-2023年、2024年-2029年
世界のドキソルビシン塩酸塩API市場：用途別市場シェア、2022年
・注射、凍結乾燥粉末注射、リポソーム注射

世界のドキソルビシン塩酸塩API市場：地域・国別、2018年-2023年、2024年-2029年
世界のドキソルビシン塩酸塩API市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるドキソルビシン塩酸塩APIのグローバル売上、2018年-2023年
・主要企業におけるドキソルビシン塩酸塩APIのグローバル売上シェア、2022年
・主要企業におけるドキソルビシン塩酸塩APIのグローバル販売量、2018年-2023年
・主要企業におけるドキソルビシン塩酸塩APIのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Intas Pharmaceuticals Ltd、 Olon Spa、 Sterling Biotech Ltd、 Synbias Pharma Ag、 Teva Pharmaceutical Industries Ltd、 Meiji Seika Pharma Co Ltd、 Microbiopharm Japan Co Ltd、 Pharmacia And Upjohn Co、 Boryung Pharmaceutical、 Transo-Pharm Handels Gmbh、 Dzd Heze Pharmaceutical Co Ltd、 Zhejiang Hisun Pharmaceutical、 Guangdong Lingnan Pharmaceutical

*************************************************************

・調査・分析レポートの概要
ドキソルビシン塩酸塩API市場の定義
市場セグメント
世界のドキソルビシン塩酸塩API市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のドキソルビシン塩酸塩API市場規模
世界のドキソルビシン塩酸塩API市場規模：2022年 VS 2029年
世界のドキソルビシン塩酸塩API市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのドキソルビシン塩酸塩APIの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のドキソルビシン塩酸塩API製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：純度≧98%、純度<98%
ドキソルビシン塩酸塩APIのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：注射、凍結乾燥粉末注射、リポソーム注射
ドキソルビシン塩酸塩APIの用途別グローバル売上・予測

・地域別市場分析
地域別ドキソルビシン塩酸塩API市場規模 2022年と2029年
地域別ドキソルビシン塩酸塩API売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Intas Pharmaceuticals Ltd、 Olon Spa、 Sterling Biotech Ltd、 Synbias Pharma Ag、 Teva Pharmaceutical Industries Ltd、 Meiji Seika Pharma Co Ltd、 Microbiopharm Japan Co Ltd、 Pharmacia And Upjohn Co、 Boryung Pharmaceutical、 Transo-Pharm Handels Gmbh、 Dzd Heze Pharmaceutical Co Ltd、 Zhejiang Hisun Pharmaceutical、 Guangdong Lingnan Pharmaceutical
...

This research report provides a comprehensive analysis of the Doxorubicin Hydrochloride API market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Doxorubicin Hydrochloride API market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Doxorubicin Hydrochloride API, challenges faced by the industry, and potential opportunities for market players.
The global Doxorubicin Hydrochloride API market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Doxorubicin Hydrochloride API market presents opportunities for various stakeholders, including Injection, Freeze-dried Powder Injection. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Doxorubicin Hydrochloride API market. Additionally, the growing consumer demand present avenues for market expansion.
The global Doxorubicin Hydrochloride API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Doxorubicin Hydrochloride API market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Doxorubicin Hydrochloride API market.
Market Overview: The report provides a comprehensive overview of the Doxorubicin Hydrochloride API market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Purity≥98%, Purity<98%), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Doxorubicin Hydrochloride API market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Doxorubicin Hydrochloride API market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Doxorubicin Hydrochloride API market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Doxorubicin Hydrochloride API market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Doxorubicin Hydrochloride API market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Doxorubicin Hydrochloride API market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Doxorubicin Hydrochloride API, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Doxorubicin Hydrochloride API market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Doxorubicin Hydrochloride API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. Market segment by Type Purity≥98% Purity<98% Market segment by Application Injection Freeze-dried Powder Injection Liposomal Injection Global Doxorubicin Hydrochloride API Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Major players covered Intas Pharmaceuticals Ltd Olon Spa Sterling Biotech Ltd Synbias Pharma Ag Teva Pharmaceutical Industries Ltd Meiji Seika Pharma Co Ltd Microbiopharm Japan Co Ltd Pharmacia And Upjohn Co Boryung Pharmaceutical Transo-Pharm Handels Gmbh Dzd Heze Pharmaceutical Co Ltd Zhejiang Hisun Pharmaceutical Guangdong Lingnan Pharmaceutical Outline of Major Chapters: Chapter 1: Introduces the definition of Doxorubicin Hydrochloride API, market overview. Chapter 2: Global Doxorubicin Hydrochloride API market size in revenue and volume. Chapter 3: Detailed analysis of Doxorubicin Hydrochloride API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Doxorubicin Hydrochloride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global Doxorubicin Hydrochloride API capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Doxorubicin Hydrochloride API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Doxorubicin Hydrochloride API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Doxorubicin Hydrochloride API Overall Market Size
2.1 Global Doxorubicin Hydrochloride API Market Size: 2022 VS 2029
2.2 Global Doxorubicin Hydrochloride API Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Doxorubicin Hydrochloride API Sales: 2018-2029
3 Company Landscape
3.1 Top Doxorubicin Hydrochloride API Players in Global Market
3.2 Top Global Doxorubicin Hydrochloride API Companies Ranked by Revenue
3.3 Global Doxorubicin Hydrochloride API Revenue by Companies
3.4 Global Doxorubicin Hydrochloride API Sales by Companies
3.5 Global Doxorubicin Hydrochloride API Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Doxorubicin Hydrochloride API Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Doxorubicin Hydrochloride API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Doxorubicin Hydrochloride API Players in Global Market
3.8.1 List of Global Tier 1 Doxorubicin Hydrochloride API Companies
3.8.2 List of Global Tier 2 and Tier 3 Doxorubicin Hydrochloride API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Doxorubicin Hydrochloride API Market Size Markets, 2022 & 2029
4.1.2 Purity≥98%
4.1.3 Purity<98% 4.2 By Type - Global Doxorubicin Hydrochloride API Revenue & Forecasts 4.2.1 By Type - Global Doxorubicin Hydrochloride API Revenue, 2018-2023 4.2.2 By Type - Global Doxorubicin Hydrochloride API Revenue, 2024-2029 4.2.3 By Type - Global Doxorubicin Hydrochloride API Revenue Market Share, 2018-2029 4.3 By Type - Global Doxorubicin Hydrochloride API Sales & Forecasts 4.3.1 By Type - Global Doxorubicin Hydrochloride API Sales, 2018-2023 4.3.2 By Type - Global Doxorubicin Hydrochloride API Sales, 2024-2029 4.3.3 By Type - Global Doxorubicin Hydrochloride API Sales Market Share, 2018-2029 4.4 By Type - Global Doxorubicin Hydrochloride API Price (Manufacturers Selling Prices), 2018-2029 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Doxorubicin Hydrochloride API Market Size, 2022 & 2029 5.1.2 Injection 5.1.3 Freeze-dried Powder Injection 5.1.4 Liposomal Injection 5.2 By Application - Global Doxorubicin Hydrochloride API Revenue & Forecasts 5.2.1 By Application - Global Doxorubicin Hydrochloride API Revenue, 2018-2023 5.2.2 By Application - Global Doxorubicin Hydrochloride API Revenue, 2024-2029 5.2.3 By Application - Global Doxorubicin Hydrochloride API Revenue Market Share, 2018-2029 5.3 By Application - Global Doxorubicin Hydrochloride API Sales & Forecasts 5.3.1 By Application - Global Doxorubicin Hydrochloride API Sales, 2018-2023 5.3.2 By Application - Global Doxorubicin Hydrochloride API Sales, 2024-2029 5.3.3 By Application - Global Doxorubicin Hydrochloride API Sales Market Share, 2018-2029 5.4 By Application - Global Doxorubicin Hydrochloride API Price (Manufacturers Selling Prices), 2018-2029 6 Sights by Region 6.1 By Region - Global Doxorubicin Hydrochloride API Market Size, 2022 & 2029 6.2 By Region - Global Doxorubicin Hydrochloride API Revenue & Forecasts 6.2.1 By Region - Global Doxorubicin Hydrochloride API Revenue, 2018-2023 6.2.2 By Region - Global Doxorubicin Hydrochloride API Revenue, 2024-2029 6.2.3 By Region - Global Doxorubicin Hydrochloride API Revenue Market Share, 2018-2029 6.3 By Region - Global Doxorubicin Hydrochloride API Sales & Forecasts 6.3.1 By Region - Global Doxorubicin Hydrochloride API Sales, 2018-2023 6.3.2 By Region - Global Doxorubicin Hydrochloride API Sales, 2024-2029 6.3.3 By Region - Global Doxorubicin Hydrochloride API Sales Market Share, 2018-2029 6.4 North America 6.4.1 By Country - North America Doxorubicin Hydrochloride API Revenue, 2018-2029 6.4.2 By Country - North America Doxorubicin Hydrochloride API Sales, 2018-2029 6.4.3 US Doxorubicin Hydrochloride API Market Size, 2018-2029 6.4.4 Canada Doxorubicin Hydrochloride API Market Size, 2018-2029 6.4.5 Mexico Doxorubicin Hydrochloride API Market Size, 2018-2029 6.5 Europe 6.5.1 By Country - Europe Doxorubicin Hydrochloride API Revenue, 2018-2029 6.5.2 By Country - Europe Doxorubicin Hydrochloride API Sales, 2018-2029 6.5.3 Germany Doxorubicin Hydrochloride API Market Size, 2018-2029 6.5.4 France Doxorubicin Hydrochloride API Market Size, 2018-2029 6.5.5 U.K. Doxorubicin Hydrochloride API Market Size, 2018-2029 6.5.6 Italy Doxorubicin Hydrochloride API Market Size, 2018-2029 6.5.7 Russia Doxorubicin Hydrochloride API Market Size, 2018-2029 6.5.8 Nordic Countries Doxorubicin Hydrochloride API Market Size, 2018-2029 6.5.9 Benelux Doxorubicin Hydrochloride API Market Size, 2018-2029 6.6 Asia 6.6.1 By Region - Asia Doxorubicin Hydrochloride API Revenue, 2018-2029 6.6.2 By Region - Asia Doxorubicin Hydrochloride API Sales, 2018-2029 6.6.3 China Doxorubicin Hydrochloride API Market Size, 2018-2029 6.6.4 Japan Doxorubicin Hydrochloride API Market Size, 2018-2029 6.6.5 South Korea Doxorubicin Hydrochloride API Market Size, 2018-2029 6.6.6 Southeast Asia Doxorubicin Hydrochloride API Market Size, 2018-2029 6.6.7 India Doxorubicin Hydrochloride API Market Size, 2018-2029 6.7 South America 6.7.1 By Country - South America Doxorubicin Hydrochloride API Revenue, 2018-2029 6.7.2 By Country - South America Doxorubicin Hydrochloride API Sales, 2018-2029 6.7.3 Brazil Doxorubicin Hydrochloride API Market Size, 2018-2029 6.7.4 Argentina Doxorubicin Hydrochloride API Market Size, 2018-2029 6.8 Middle East & Africa 6.8.1 By Country - Middle East & Africa Doxorubicin Hydrochloride API Revenue, 2018-2029 6.8.2 By Country - Middle East & Africa Doxorubicin Hydrochloride API Sales, 2018-2029 6.8.3 Turkey Doxorubicin Hydrochloride API Market Size, 2018-2029 6.8.4 Israel Doxorubicin Hydrochloride API Market Size, 2018-2029 6.8.5 Saudi Arabia Doxorubicin Hydrochloride API Market Size, 2018-2029 6.8.6 UAE Doxorubicin Hydrochloride API Market Size, 2018-2029 7 Manufacturers & Brands Profiles 7.1 Intas Pharmaceuticals Ltd 7.1.1 Intas Pharmaceuticals Ltd Company Summary 7.1.2 Intas Pharmaceuticals Ltd Business Overview 7.1.3 Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Major Product Offerings 7.1.4 Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.1.5 Intas Pharmaceuticals Ltd Key News & Latest Developments 7.2 Olon Spa 7.2.1 Olon Spa Company Summary 7.2.2 Olon Spa Business Overview 7.2.3 Olon Spa Doxorubicin Hydrochloride API Major Product Offerings 7.2.4 Olon Spa Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.2.5 Olon Spa Key News & Latest Developments 7.3 Sterling Biotech Ltd 7.3.1 Sterling Biotech Ltd Company Summary 7.3.2 Sterling Biotech Ltd Business Overview 7.3.3 Sterling Biotech Ltd Doxorubicin Hydrochloride API Major Product Offerings 7.3.4 Sterling Biotech Ltd Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.3.5 Sterling Biotech Ltd Key News & Latest Developments 7.4 Synbias Pharma Ag 7.4.1 Synbias Pharma Ag Company Summary 7.4.2 Synbias Pharma Ag Business Overview 7.4.3 Synbias Pharma Ag Doxorubicin Hydrochloride API Major Product Offerings 7.4.4 Synbias Pharma Ag Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.4.5 Synbias Pharma Ag Key News & Latest Developments 7.5 Teva Pharmaceutical Industries Ltd 7.5.1 Teva Pharmaceutical Industries Ltd Company Summary 7.5.2 Teva Pharmaceutical Industries Ltd Business Overview 7.5.3 Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Major Product Offerings 7.5.4 Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.5.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments 7.6 Meiji Seika Pharma Co Ltd 7.6.1 Meiji Seika Pharma Co Ltd Company Summary 7.6.2 Meiji Seika Pharma Co Ltd Business Overview 7.6.3 Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Major Product Offerings 7.6.4 Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.6.5 Meiji Seika Pharma Co Ltd Key News & Latest Developments 7.7 Microbiopharm Japan Co Ltd 7.7.1 Microbiopharm Japan Co Ltd Company Summary 7.7.2 Microbiopharm Japan Co Ltd Business Overview 7.7.3 Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Major Product Offerings 7.7.4 Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.7.5 Microbiopharm Japan Co Ltd Key News & Latest Developments 7.8 Pharmacia And Upjohn Co 7.8.1 Pharmacia And Upjohn Co Company Summary 7.8.2 Pharmacia And Upjohn Co Business Overview 7.8.3 Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Major Product Offerings 7.8.4 Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.8.5 Pharmacia And Upjohn Co Key News & Latest Developments 7.9 Boryung Pharmaceutical 7.9.1 Boryung Pharmaceutical Company Summary 7.9.2 Boryung Pharmaceutical Business Overview 7.9.3 Boryung Pharmaceutical Doxorubicin Hydrochloride API Major Product Offerings 7.9.4 Boryung Pharmaceutical Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.9.5 Boryung Pharmaceutical Key News & Latest Developments 7.10 Transo-Pharm Handels Gmbh 7.10.1 Transo-Pharm Handels Gmbh Company Summary 7.10.2 Transo-Pharm Handels Gmbh Business Overview 7.10.3 Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Major Product Offerings 7.10.4 Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.10.5 Transo-Pharm Handels Gmbh Key News & Latest Developments 7.11 Dzd Heze Pharmaceutical Co Ltd 7.11.1 Dzd Heze Pharmaceutical Co Ltd Company Summary 7.11.2 Dzd Heze Pharmaceutical Co Ltd Business Overview 7.11.3 Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Major Product Offerings 7.11.4 Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.11.5 Dzd Heze Pharmaceutical Co Ltd Key News & Latest Developments 7.12 Zhejiang Hisun Pharmaceutical 7.12.1 Zhejiang Hisun Pharmaceutical Company Summary 7.12.2 Zhejiang Hisun Pharmaceutical Business Overview 7.12.3 Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Major Product Offerings 7.12.4 Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.12.5 Zhejiang Hisun Pharmaceutical Key News & Latest Developments 7.13 Guangdong Lingnan Pharmaceutical 7.13.1 Guangdong Lingnan Pharmaceutical Company Summary 7.13.2 Guangdong Lingnan Pharmaceutical Business Overview 7.13.3 Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Major Product Offerings 7.13.4 Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Sales and Revenue in Global (2018-2023) 7.13.5 Guangdong Lingnan Pharmaceutical Key News & Latest Developments 8 Global Doxorubicin Hydrochloride API Production Capacity, Analysis 8.1 Global Doxorubicin Hydrochloride API Production Capacity, 2018-2029 8.2 Doxorubicin Hydrochloride API Production Capacity of Key Manufacturers in Global Market 8.3 Global Doxorubicin Hydrochloride API Production by Region 9 Key Market Trends, Opportunity, Drivers and Restraints 9.1 Market Opportunities & Trends 9.2 Market Drivers 9.3 Market Restraints 10 Doxorubicin Hydrochloride API Supply Chain Analysis 10.1 Doxorubicin Hydrochloride API Industry Value Chain 10.2 Doxorubicin Hydrochloride API Upstream Market 10.3 Doxorubicin Hydrochloride API Downstream and Clients 10.4 Marketing Channels Analysis 10.4.1 Marketing Channels 10.4.2 Doxorubicin Hydrochloride API Distributors and Sales Agents in Global 11 Conclusion 12 Appendix 12.1 Note 12.2 Examples of Clients 12.3 Disclaimer

List of Tables
Table 1. Key Players of Doxorubicin Hydrochloride API in Global Market
Table 2. Top Doxorubicin Hydrochloride API Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Doxorubicin Hydrochloride API Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Doxorubicin Hydrochloride API Revenue Share by Companies, 2018-2023
Table 5. Global Doxorubicin Hydrochloride API Sales by Companies, (Tons), 2018-2023
Table 6. Global Doxorubicin Hydrochloride API Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Doxorubicin Hydrochloride API Price (2018-2023) & (US$/Ton)
Table 8. Global Manufacturers Doxorubicin Hydrochloride API Product Type
Table 9. List of Global Tier 1 Doxorubicin Hydrochloride API Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Doxorubicin Hydrochloride API Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Doxorubicin Hydrochloride API Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Doxorubicin Hydrochloride API Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Doxorubicin Hydrochloride API Sales (Tons), 2018-2023
Table 15. By Type - Global Doxorubicin Hydrochloride API Sales (Tons), 2024-2029
Table 16. By Application – Global Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Doxorubicin Hydrochloride API Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Doxorubicin Hydrochloride API Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Doxorubicin Hydrochloride API Sales (Tons), 2018-2023
Table 20. By Application - Global Doxorubicin Hydrochloride API Sales (Tons), 2024-2029
Table 21. By Region – Global Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Doxorubicin Hydrochloride API Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Doxorubicin Hydrochloride API Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Doxorubicin Hydrochloride API Sales (Tons), 2018-2023
Table 25. By Region - Global Doxorubicin Hydrochloride API Sales (Tons), 2024-2029
Table 26. By Country - North America Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Doxorubicin Hydrochloride API Sales, (Tons), 2018-2023
Table 29. By Country - North America Doxorubicin Hydrochloride API Sales, (Tons), 2024-2029
Table 30. By Country - Europe Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Doxorubicin Hydrochloride API Sales, (Tons), 2018-2023
Table 33. By Country - Europe Doxorubicin Hydrochloride API Sales, (Tons), 2024-2029
Table 34. By Region - Asia Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Doxorubicin Hydrochloride API Sales, (Tons), 2018-2023
Table 37. By Region - Asia Doxorubicin Hydrochloride API Sales, (Tons), 2024-2029
Table 38. By Country - South America Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Doxorubicin Hydrochloride API Sales, (Tons), 2018-2023
Table 41. By Country - South America Doxorubicin Hydrochloride API Sales, (Tons), 2024-2029
Table 42. By Country - Middle East & Africa Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Doxorubicin Hydrochloride API Sales, (Tons), 2018-2023
Table 45. By Country - Middle East & Africa Doxorubicin Hydrochloride API Sales, (Tons), 2024-2029
Table 46. Intas Pharmaceuticals Ltd Company Summary
Table 47. Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Product Offerings
Table 48. Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 49. Intas Pharmaceuticals Ltd Key News & Latest Developments
Table 50. Olon Spa Company Summary
Table 51. Olon Spa Doxorubicin Hydrochloride API Product Offerings
Table 52. Olon Spa Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 53. Olon Spa Key News & Latest Developments
Table 54. Sterling Biotech Ltd Company Summary
Table 55. Sterling Biotech Ltd Doxorubicin Hydrochloride API Product Offerings
Table 56. Sterling Biotech Ltd Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 57. Sterling Biotech Ltd Key News & Latest Developments
Table 58. Synbias Pharma Ag Company Summary
Table 59. Synbias Pharma Ag Doxorubicin Hydrochloride API Product Offerings
Table 60. Synbias Pharma Ag Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 61. Synbias Pharma Ag Key News & Latest Developments
Table 62. Teva Pharmaceutical Industries Ltd Company Summary
Table 63. Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Product Offerings
Table 64. Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 65. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 66. Meiji Seika Pharma Co Ltd Company Summary
Table 67. Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Product Offerings
Table 68. Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 69. Meiji Seika Pharma Co Ltd Key News & Latest Developments
Table 70. Microbiopharm Japan Co Ltd Company Summary
Table 71. Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Product Offerings
Table 72. Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 73. Microbiopharm Japan Co Ltd Key News & Latest Developments
Table 74. Pharmacia And Upjohn Co Company Summary
Table 75. Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Product Offerings
Table 76. Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 77. Pharmacia And Upjohn Co Key News & Latest Developments
Table 78. Boryung Pharmaceutical Company Summary
Table 79. Boryung Pharmaceutical Doxorubicin Hydrochloride API Product Offerings
Table 80. Boryung Pharmaceutical Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 81. Boryung Pharmaceutical Key News & Latest Developments
Table 82. Transo-Pharm Handels Gmbh Company Summary
Table 83. Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Product Offerings
Table 84. Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 85. Transo-Pharm Handels Gmbh Key News & Latest Developments
Table 86. Dzd Heze Pharmaceutical Co Ltd Company Summary
Table 87. Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Product Offerings
Table 88. Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 89. Dzd Heze Pharmaceutical Co Ltd Key News & Latest Developments
Table 90. Zhejiang Hisun Pharmaceutical Company Summary
Table 91. Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Product Offerings
Table 92. Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 93. Zhejiang Hisun Pharmaceutical Key News & Latest Developments
Table 94. Guangdong Lingnan Pharmaceutical Company Summary
Table 95. Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Product Offerings
Table 96. Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 97. Guangdong Lingnan Pharmaceutical Key News & Latest Developments
Table 98. Doxorubicin Hydrochloride API Production Capacity (Tons) of Key Manufacturers in Global Market, 2021-2023 (Tons)
Table 99. Global Doxorubicin Hydrochloride API Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Doxorubicin Hydrochloride API Production by Region, 2018-2023 (Tons)
Table 101. Global Doxorubicin Hydrochloride API Production by Region, 2024-2029 (Tons)
Table 102. Doxorubicin Hydrochloride API Market Opportunities & Trends in Global Market
Table 103. Doxorubicin Hydrochloride API Market Drivers in Global Market
Table 104. Doxorubicin Hydrochloride API Market Restraints in Global Market
Table 105. Doxorubicin Hydrochloride API Raw Materials
Table 106. Doxorubicin Hydrochloride API Raw Materials Suppliers in Global Market
Table 107. Typical Doxorubicin Hydrochloride API Downstream
Table 108. Doxorubicin Hydrochloride API Downstream Clients in Global Market
Table 109. Doxorubicin Hydrochloride API Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Doxorubicin Hydrochloride API Segment by Type in 2022
Figure 2. Doxorubicin Hydrochloride API Segment by Application in 2022
Figure 3. Global Doxorubicin Hydrochloride API Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Doxorubicin Hydrochloride API Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Doxorubicin Hydrochloride API Revenue, 2018-2029 (US$, Mn)
Figure 7. Doxorubicin Hydrochloride API Sales in Global Market: 2018-2029 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Doxorubicin Hydrochloride API Revenue in 2022
Figure 9. By Type - Global Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Doxorubicin Hydrochloride API Revenue Market Share, 2018-2029
Figure 11. By Type - Global Doxorubicin Hydrochloride API Sales Market Share, 2018-2029
Figure 12. By Type - Global Doxorubicin Hydrochloride API Price (US$/Ton), 2018-2029
Figure 13. By Application - Global Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Doxorubicin Hydrochloride API Revenue Market Share, 2018-2029
Figure 15. By Application - Global Doxorubicin Hydrochloride API Sales Market Share, 2018-2029
Figure 16. By Application - Global Doxorubicin Hydrochloride API Price (US$/Ton), 2018-2029
Figure 17. By Region - Global Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Doxorubicin Hydrochloride API Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Doxorubicin Hydrochloride API Revenue Market Share, 2018-2029
Figure 20. By Region - Global Doxorubicin Hydrochloride API Sales Market Share, 2018-2029
Figure 21. By Country - North America Doxorubicin Hydrochloride API Revenue Market Share, 2018-2029
Figure 22. By Country - North America Doxorubicin Hydrochloride API Sales Market Share, 2018-2029
Figure 23. US Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Doxorubicin Hydrochloride API Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Doxorubicin Hydrochloride API Sales Market Share, 2018-2029
Figure 28. Germany Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 29. France Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Doxorubicin Hydrochloride API Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Doxorubicin Hydrochloride API Sales Market Share, 2018-2029
Figure 37. China Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 41. India Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Doxorubicin Hydrochloride API Revenue Market Share, 2018-2029
Figure 43. By Country - South America Doxorubicin Hydrochloride API Sales Market Share, 2018-2029
Figure 44. Brazil Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Doxorubicin Hydrochloride API Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Doxorubicin Hydrochloride API Sales Market Share, 2018-2029
Figure 48. Turkey Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Doxorubicin Hydrochloride API Revenue, (US$, Mn), 2018-2029
Figure 52. Global Doxorubicin Hydrochloride API Production Capacity (Tons), 2018-2029
Figure 53. The Percentage of Production Doxorubicin Hydrochloride API by Region, 2022 VS 2029
Figure 54. Doxorubicin Hydrochloride API Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ジエチルアミン塩酸塩のグローバル市場展望 2023年-2029年：純度99%、その他
  • (3-クロロピラジン-2-イル)メタンアミン二塩酸塩のグローバル市場展望 2023年-2029年：純度≧97%、純度≧98%
  • エピルビシン塩酸塩APIのグローバル市場展望 2023年-2029年：純度≧99%、純度<99%
  • ナファゾリン塩酸塩点鼻薬のグローバル市場展望 2023年-2029年：5ml、10ml
  • ダポキセチン塩酸塩APIのグローバル市場展望 2023年-2029年：純度99.5%以上、純度99.9%以上
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC01782 )"ドキソルビシン塩酸塩APIのグローバル市場展望 2023年-2029年：純度≧98%、純度<98%" (英文：Doxorubicin Hydrochloride API Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。